NCT02122536View on ClinicalTrials.gov

Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2013

Conditions
Facial Wrinkles
Interventions
DRUG

Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects

Subjects were randomized to which side of the face would be treated with Xeomin.

DRUG

Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects

Subjects were randomized to which side of the upper face would be treated with Botox

Trial Locations (1)

34239

Center for Sight, Sarasota

All Listed Sponsors
lead

YMD Eye and Face

OTHER

NCT02122536 - Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles | Biotech Hunter | Biotech Hunter